Abstract
Our findings suggested a positive association between serum 25(OH)D<sub>2</sub> concentrations and both LFHL and SFHL in the studied cohort. Additionally, an L-shaped relationship was found between serum 25(OH)D<sub>3</sub> and LFHL and SFHL, and higher levels of serum 25(OH)D<sub>3</sub> were identified to be associated with a lower risk of HFHL.
Introduction
Hearing loss (HL) is a significant global health concern, affecting over 5% of the population. While nutritional factors, particularly Vitamin D, have long been suspected to play a role in auditory health due to their influence on bone mineralization in the cochlea and nerve function, most research has focused on "total" Vitamin D. This study, published in Frontiers in Nutrition, investigates whether the two primary forms of Vitamin D—Vitamin D3 (synthesized via sunlight or animal products) and Vitamin D2 (derived from plants and supplements)—have distinct impacts on hearing across different frequencies.
Methods and Study Population
The researchers conducted a cross-sectional analysis using data from the 2015–2016 National Health and Nutrition Examination Survey (NHANES). The study focused on adults aged 20–69. Serum levels of 25(OH)D2 and 25(OH)D3 were measured using high-performance liquid chromatography–tandem mass spectrometry (HPLC-MS/MS), the gold standard for distinguishing these biomarkers. Hearing was assessed via audiometry across three categories: Low-frequency (LFHL), Speech-frequency (SFHL), and High-frequency (HFHL).
Key Results: The D2/D3 Divergence
The study revealed a striking divergence in how these two forms of Vitamin D relate to hearing health. While Vitamin D3 generally showed a protective effect, higher levels of Vitamin D2 were unexpectedly associated with an increased risk of hearing impairment.
The "D2 Paradox"
For Vitamin D2, each unit increase in serum concentration was associated with a 1.2% increase in risk for low-frequency hearing loss and a 1.1% increase for speech-frequency hearing loss. This linear relationship suggests that higher D2 levels may negatively impact auditory function, possibly by competitively inhibiting the activation of the more effective Vitamin D3.
Threshold Effects and the L-Shaped Relationship
In contrast, Vitamin D3 exhibited a protective "L-shaped" relationship with hearing loss. The risk of impairment dropped significantly as Vitamin D3 levels rose, until reaching a specific threshold where the benefit plateaued.
Critical inflection points for Vitamin D3 were identified at: * 35.3 nmol/L for Low-frequency HL. * 36.5 nmol/L for Speech-frequency HL. * 53.9 nmol/L for High-frequency HL.
Discussion and Limitations
The findings suggest that "total Vitamin D" measurements may obscure critical metabolic differences. The "Competition Hypothesis" proposed by the authors suggests that an excess of D2 might inadvertently lower the body's overall auditory-protective capacity by interfering with D3 metabolism. Furthermore, a significant interaction was noted with diabetes; in non-diabetic populations, the negative association between D2 and hearing health was particularly pronounced.
Study Limitations
As a cross-sectional study, these results represent a snapshot in time and cannot establish direct causality. Vitamin D levels are known to fluctuate seasonally, and a single measurement may not reflect long-term status. Additionally, the study could not account for potential confounders like parathyroid hormone levels or specific bone density markers.
Conclusion
This research highlights the importance of distinguishing between Vitamin D2 and D3 in clinical and nutritional assessments of hearing health. Future longitudinal studies and clinical trials are necessary to determine if targeted Vitamin D3 supplementation can effectively prevent or slow the progression of hearing loss in adults.
Summary updated